Jumat, 05 Juni 2026 - 01:06 WIB

Find and Follow Us

Global Markets

IHSG 5,839.79 -1.70%

S&P 500 7,592.82 +0.52%

NASDAQ 26,911.61 +0.21%

Dow Jones 51,499.97 +1.60%

FTSE 100 10,360.32 +0.27%

CAC 40 8,244.29 +1.15%

Nikkei 225 67,470.69 -1.36%

Hang Seng 25,253.40 -1.48%

Shanghai 4,057.78 -0.64%

KOSPI 8,639.41 -1.84%

STI 5,067.53 -1.38%

ASX 200 8,686.10 -1.13%

Sensex 74,360.01 +0.02%

Gold 4,506.30 +1.57%

Silver 74.15 +0.92%

Oil (WTI) 92.32 -3.85%

Brent 94.64 -3.24%

Copper 6.55 +0.99%

Gas Alam 3.36 +4.42%

Bitcoin 63,260.03 -1.18%

Ethereum 1,762.10 -2.74%

USD/IDR 18,034.00 +0.99%

EUR/USD 1.16 +0.02%

Advertisement

Director of Research & Business Development Dexa Group, Dr. Raymond Tjandrawinata

Green Pharmacy Harus Jadi Obat Integratif untuk Pengobatan Konvensional

Redaksi • 06 September 2022

Latest Updates

- Advertisement -

Director of Research & Business Development Dexa Group, Dr. Raymond Tjandrawinata

17:45 WIB • 06 September 2022

Green Pharmacy Harus Jadi Obat Integratif untuk Pengobatan Konvensional

Lead Chair T20 Prof Bambang Brodjonegoro mengatakan, untuk berkomitmen dalam sektor kesehatan diperkukan kolaborasi dan…